glp-1 cardiovascular outcomes trial august 2025 Comparative effectiveness of newer glucose-lowering drugs in elderly with type 2 diabetes: a target emulation cohort study SELECT Trial

The primary endpoint, change of weight loss over time, was analyzed by repeated-measures ANOVA comparing patients with GLP-1-RAs plus usual care weight management (GLP-1-RA group) to patients with usual care weight management only (UCWM)

Hormone-Friendly Weight Loss Our solutions are ideal for women in menopause or anyone dealing with hormone-related weight struggles, offering a gentle way to reset metabolism without harsh interventions

premenopausal women, older adults) Monitoring should be risk-based, not routine by default

When using semaglutide, avoid rapid dose escalation as it can cause GI upset, vomiting, abdominal pain, and diarrhea

And to do this, we looked at the iqvia prescription and medical claims data, we can tag that on the basis of whether the claim came from a pharmacy setting or not